Daiwa Securities Group Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1
-50.0%
3310.0%0.00%
Q1 2024$2
-33.3%
3310.0%0.00%
Q4 2023$3
-25.0%
3310.0%0.00%
Q3 2023$4
-50.0%
3310.0%0.00%
Q2 2023$8
-27.3%
3310.0%0.00%
Q1 2023$11
+83.3%
3310.0%0.00%
Q4 2022$6
-99.9%
331
+34.6%
0.00%
Q3 2022$7,000
+133.3%
2460.0%0.00%
Q2 2022$3,000
-40.0%
2460.0%0.00%
Q1 2022$5,000
+25.0%
2460.0%0.00%
Q4 2021$4,000
-42.9%
2460.0%0.00%
Q3 2021$7,000
+75.0%
246
+74.5%
0.00%
Q2 2021$4,0000.0%1410.0%0.00%
Q1 2021$4,0000.0%141
+12.8%
0.00%
Q4 2020$4,000
-50.0%
125
-60.6%
0.00%
Q3 2020$8,000
+60.0%
3170.0%0.00%
Q2 2020$5,0000.0%3170.0%0.00%
Q1 2020$5,0000.0%317
+13.2%
0.00%
Q4 2019$5,000
+25.0%
2800.0%0.00%
Q3 2019$4,0000.0%2800.0%0.00%
Q2 2019$4,0000.0%2800.0%0.00%
Q1 2019$4,0000.0%280
+38.6%
0.00%
Q4 2018$4,000
-20.0%
2020.0%0.00%
Q3 2018$5,000
-16.7%
2020.0%0.00%
Q2 2018$6,0000.0%2020.0%0.00%
Q1 2018$6,0002020.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders